Will Nano One Materials Corp (NANO) Beat Estimates Again in Its Next Earnings Report?

Nano One has beaten EPS estimates in three of its last four reported quarters. But this earnings report is less about reaching a profit milestone and more about whether the company is moving closer to commercial production.

Nano One Materials Corp. (TSX: NANO) is scheduled to report results after market close on November 9, 2026, for the quarter ended September 30. One analyst’s EPS consensus is a loss of C$0.06 per share. The earnings calendar lists a C$0.07 loss, so the estimates differ. Nano One has beaten estimates in three of its last four comparable quarters, but it remains unprofitable, with trailing EPS of -C$0.14. For Canadian investors, the key question is how quarterly spending and operating progress fit into the company’s plans to move from materials development to commercial production.

Recent earnings trend

Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.

Beat estimates in 3 of the last 4 comparable quarter(s).

Investor takeaway: NANO.TO has a record of beating estimates, but an EPS surprise alone would not show that commercialization is advancing. Watch the reported loss and comments on cash needs, Candiac construction, customer qualification and the timeline for a commercial agreement. The consensus is based on one analyst, and the two supplied EPS estimates differ.

C$0.06 loss per share

That’s the one-analyst EPS consensus for the September quarter. The earnings calendar lists a C$0.07 loss. Either way, investors will want to see whether the results and management’s update show progress toward commercialization.

Analysis

Nano One is due to report after market close on November 9, 2026, for the quarter ended September 30. The trends data shows an EPS consensus of -C$0.06, based on one analyst. The earnings calendar lists an estimate of -C$0.07. Both figures point to a quarterly loss, but the difference matters when comparing the reported result. Revenue consensus is listed as zero from one analyst, so the supplied data offers no useful revenue benchmark. The EPS estimate has not changed in the past 30 days.

Nano One has beaten estimates in three of its last four reported quarters. Its broader history includes 13 quarters with actual and estimated EPS. In June 2026, the company reported a loss of C$0.04 per share against an estimated loss of C$0.05. That record makes another smaller-than-expected loss possible, but it does not guarantee one. The company remains unprofitable, with trailing EPS of -C$0.14.

Investors following the Nano One stock page can compare the upcoming result with the earnings trend table and chart. The main question is not just whether the loss is smaller than one analyst expects. It’s whether the financial results and management’s comments fit with Nano One’s longer-term commercialization plans.

Analysis

Recent company updates point to several developments investors can check in the report or management’s comments. Nano One says construction has started on its Candiac expansion. The company targets completion in the first quarter of 2027 and commissioning in the second quarter. The expanded facility is expected to produce about 800 tonnes a year, and Nano One now expects its first commercial agreement in the first quarter of 2027. These are future targets, not completed milestones.

Nano One has also reported positive customer feedback on One-Pot LFP samples. Qualification is ongoing, and the company has not secured commercial offtake. Feedstock qualification is another part of the work. Nano One says it has pre-qualified sources of lithium carbonate and phosphoric acid, while iron sources are being validated. The company says qualification can take up to two years.

A larger proposed Canadian LFP facility is at an earlier stage. Nano One has started evaluating sites and developing plans for a project initially outlined at 25,000 tonnes a year, with potential expansion to 100,000 tonnes. Site selection, partners, financing and customer arrangements are still under development. Investors can use the report to check whether these plans remain on schedule and whether the company has secured any new commercial commitments. In September, Nano One also announced that its board chair would take on interim CEO duties while CEO Alex Holmes is on medical leave.

The NANO analyst-ratings section lists an average target of C$2.00, compared with a last close of C$0.73. That implies a difference of 174%. The supplied context says a formal rating is unavailable for Canadian listings, so this comparison is not a guaranteed outcome or a consensus rating. Nano One’s statistical price forecast is a separate model, not investment advice. It gives a 90-day mean of C$0.64, with a 68% range of C$0.51 to C$0.79 and a 95% range of C$0.41 to C$0.99. Analyst targets and model forecasts use different methods and time frames. Neither removes the company’s execution risks.

Analysis

The positive case rests on Nano One’s estimate history and steps toward production. Construction is underway at Candiac, customers are evaluating samples, and the company is qualifying feedstock sources. If Nano One meets or beats the available EPS estimates and reports credible progress on these milestones, investors may see signs that its development work is advancing.

The risks remain significant. Nano One is losing money, customer qualification is not the same as a commercial order, and the Candiac expansion has not reached commissioning. The larger proposed facility still needs key decisions and agreements. The consensus comes from one analyst, and the two supplied EPS estimates differ. A quarterly beat would be one data point, not proof of a sustainable business or a completed shift to commercial production.

For Canadian investors, the checklist is simple: compare actual EPS with the estimate used by your data source, review comments on spending and funding needs, and look for specific updates on construction, qualification and the commercial-agreement timeline. In the supplied technical snapshot, the share price was below its 50-day and 200-day moving averages. That context does not replace a review of the company’s operating progress.